Corporate ActionMay 26, 2026, 05:12 PM
Traws Pharma Updates ATM Offering to $3.13M Under Baby Shelf
AI Summary
Traws Pharma, Inc. announced an update to its At The Market (ATM) Offering Agreement with Citizens JMP Securities, LLC. The company may now offer and sell shares of its common stock with an aggregate offering price of up to $3,128,399. This updated limit reflects the company's current "baby shelf" limitation under General Instruction I.B.6. of Form S-3, utilizing its effective shelf registration statement and recent prospectus supplements.
Key Highlights
- Traws Pharma updated its At The Market (ATM) Offering Agreement.
- The company can now offer and sell common stock up to an aggregate price of $3,128,399.
- This limit is due to the current "baby shelf" limitation under Form S-3.
- The original ATM Agreement, entered March 10, 2025, was for up to $50,000,000.
- Citizens JMP Securities, LLC acts as the sales agent and/or principal.
- Sales are conducted under an effective shelf registration statement on Form S-3.
- Prospectus supplements were filed on March 10, 2025, April 7, 2025, and May 22, 2026.
Price Impact
More from TRAW